Ignore the noise: Hereâs opportunity *Sponsored by TD Media With all the chaos unfolding in the Middle East, and the presidential race heating up, the news cycle is getting loud ð£. The same uncertainty that was there during COVID and the riots that followed makes it feel like fear is really back. That means emotion is governing the markets. Sober assessments of P/E ratios, balance sheets, and corporate governance are still relevant, but are taking a back seat. At times like these, it makes sense to narrow our focus⦠We donât want to be going long on positions that leave us exposed to geopolitical winds we canât possibly predict. Thatâs why last week I sent you two âBright Ideas ð¡â that I felt had imminent potential. One of them has traded essentially sideways (I think itâs still just gathering steam)... but the other⦠It rocketed ð33% within two days of my alert: I had followed both companies for a while, but as I explained last week, my decision to alert them leaned heavily on the âgo/no goâ algorithm â a computer-generated indicator that distills over a dozen different momentum indicators to make a best prediction of where a stock is going. I pointed out that a major green light I look for is âmultiple, conflicting go/no-go markers along the trendline just before the chart [legs] up. These mixed signals are a classic indicator Iâve seen play out countless times before reversals.â Well, folks, yesterday as I was surveying some of my favorite small caps, I came across one thatâs flashing green so clearly I knew I had to bring it to your attention⦠Right now, the only stock you need to have eyes on ð is: Avalon GloboCare Corp (Nasdaq: ALBT) Have a look at this: Drawdown â
⦠flatline â
⦠mixed go/no go signals â
â
â
â
â
â
⦠This is looking like a picture-perfect setup for a reversal. And take a look at the left side of the chart. Right there, you can see a cluster of mixed go/no goâs that preceded a 35% rally⦠and that was just a few weeks ago. Yahoo! is also confirming things. Flashing green lights in the short- and medium-term: Digging in further, there I found other reasons for excitement⦠Key asset is making ârapid progress toward commercializationâ At its core, ALBT is a medical diagnostics company. This includes in-person testing facilities for drug testing, clinical screening, COVID testing, and so on⦠But it also includes a cool system the company is looking to bring to peopleâs homes. KetoAir⢠is an FDA-registered breathalyzer that monitors ketone levels by quantifying the amount of acetone in the breath. If you arenât familiar with ketones, theyâre acids your body makes when it burns fat instead of sugar for energy⦠Back in my day, low-fat diets were all the rage, but the trendy thing over the past decade or so has been low-carb dieting. When carbs are cut down very low, the body enters âketosisâ and ketone levels go way up. But for those practicing âketogenicâ dieting, knowing whether youâre in ketosis or not is pretty much a guessing game. Serious adherents can use âketo stripsâ to do at-home urinalysis, but for obvious reasons, thatâs unappealing, and the results arenât very clear. Enter KetoAirâ¢, which allows quick (and sanitary!) ketone readings delivered straight to your smartphone, followed by customized recommendations by an artificial intelligence (AI) nutritionist. The [big news]( out this month is that the KetoAir⢠app is now approved on the Apple App store (it was already on the Google Play store). The company [said]( back in July that it was making ârapid progress towards commercialization of the KetoAir⢠breathalyzer device and related accessoriesâ and that it was âevaluating options for commercialization, including identifying distribution partners or distributing KetoAir⢠ourselves.â The App store news tells me the company is getting closer to achieving this goal. ALBT [only just acquired]( the distribution rights to KetoAir⢠this year, and has its sights set not only on North America, but South America, the United Kingdom, and the European Union as well. This is a very promising system, and once it starts rolling off assembly lines and into dietersâ hungry hands, it should generate major revenue for ALBT. New acquisitions Also earlier this year, ALBT acquired a 40% stake in Laboratory Services MSO (âLSMâ), a lab based in Costa Mesa, California, [that brought in]( $14 million in revenue and $6 million in net income in 2022. But here is the [interesting part]( that not many traders know about. Just last month, LSM acquired Merlin Medical Supply, a âprofitable, well-established Home Medical Equipment (âHMEâ) and Durable Medical Equipment (âDMEâ) company ... in Ventura County, California.â LSM also acquired a company called Leading Edge Innovations from the same owner as MMS. The importance? âLeading Edge Innovations owns the GeeWhiz External Condom Catheter, a patented, FDA-registered, in-market, male incontinence device.â For the sake of you, dear reader, I researched GeeWhiz (so you donât have to!) and was able to find it easily at many medical supply stores online. It even has a [Facebook page](! Two months ago, LSM [announced]( its expansion to Arizona, with a new lab called Veritas Laboratories opening in Scottsdale. I was intrigued to learn that the company had engaged former congressman Barry M. Goldwater, Jr. (the son of the famous presidential nominee) to help expand its footprint in Arizona. âLSM continues to grow its testing footprint nationwide by expanding to new states and territories,â the ALBT CEO said in a statement. By expanding its ownership of diagnostics centers, ALBT is shoring up more reliable revenue streams even as it works toward getting KetoAir⢠to market⦠I like this diversified approach because it blends higher-risk pursuits with lower-risk sources of revenue. I think this bodes well for the companyâs future bottom line. Wrapping up ALBT is worth your attention right now as a âbottom-bounce play.â For the past three weeks, the stock has traded sideways â indicating a strong floor of resistance â and the go/no go algorithm is signaling a breakout like we saw on last weekâs idea could be imminent. There are a number of more âfundamentalâ factors that could add fuel to the breakout, and I like the moves the company is making to expand its revenue streams. At the very least, I think ALBT merits your attention right now. Just like I said for last weekâs idea before it popped 33%, âThis is an opportunity that might be gone before you know it.â Emotion is ruling the day in the markets, yes, but itâs up to us to do our due diligence on these targeted opportunities. Scour the [companyâs website](, study its [chart](, and decide if ALBT is something that fits your risk appetite. In the meantime, Iâll keep hunting for small-cap opportunities and hopefully be in touch soon with more choice cuts. To Your Success, Jeff Bishop *This investment involves substantial risk. Please see full disclosure below, and detailed discussion of risks and atypical results. Full Disclaimer RagingBull, LLC
62 Calef Hwy. #233, Lee, NH 03861 [Manage your email subscriptions.]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneysâ fees, costs and disbursements in addition to any other relief to which it may be entitled. If you have a current active subscription with Bullseye Trades you will need to contact us if you want to cancel your subscription. Opting out of emails does not remove you from your service at Bullseye Trades.